Managing Your Practice

COVID-SAFE: Strategies for safeguarding your outpatient clinical practice against COVID-19

Author and Disclosure Information

 

References

  • Employees can work on alternating days or during different parts of the day.
  • Administrative staff who do not need to be physically present in the office might work remotely.
  • Expanding office hours (early morning, evening, and weekends) spreads patient visits throughout the day and minimizes high-volume in-person visits.

Institute a daily COVID-19 symptom attestation and temperature check for employees on arrival at work.

Health care personnel with symptoms of COVID-19 should be prioritized for SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) RNA testing with an approved nucleic acid or antigen detection assay. A negative result indicates that the person most likely did not have an active SARS-CoV-2 infection at the time the sample was collected. A second test for SARS-CoV-2 RNA may be performed at the discretion of the evaluating health care provider, particularly when a higher level of clinical suspicion for infection exists.

The return to work decision should be determined by an agreed on symptom-based approach to clearance. If needed on a case-by-case basis, a review can be performed with the individual’s health care provider.12

Require universal masking and appropriate protective equipment.

  • All staff members, patients, and visitors must wear masks correctly in the facilities (except children under age 2).
  • All clinical staff members must wear masks correctly and eye protection during every patient encounter.

Reconfigure the waiting room and patient flow.

  • Configure waiting room furniture to reinforce 6 feet of physical distancing.
  • Remove all books, magazines, and toys from all waiting areas.
  • Laminate signage for display.
  • Install plexiglass at the check-in desk to minimize virus transmission.
  • If possible, ask patients to wait in their car until their appointment time or to go directly to their exam room on arrival if it is available.
  • Implement virtual check-in and check-out so that patients reduce unnecessary contact with surfaces and staff.
  • Limit a high volume of patients to maintain social distancing etiquette, avoid delays, and allow adequate cleaning time between patients.
  • Permit visitors to accompany adult patients to their ambulatory appointments only if special assistance is required.
  • Limit the number of staff members in the exam and treatment rooms and maintain at least 6 feet between people except during medical care activities.
  • Consider patient flow in a one-way traffic pattern.

Focus on keeping the clinical practice clean. (Follow the instructions and disinfect with a registered disinfectant product that meets the US Environmental Protection Agency criteria for use against COVID-19.13)

  • Clean waiting rooms and restrooms frequently.
  • Coordinate patient appointments to allow for infection control measures.
  • Frequently clean high-touch surfaces, including tables, doorknobs, light switches, countertops, handles, desks, phones, keyboards, toilets, faucets, and sinks.
  • Clinicians and all medical staff members should wash their hands before and after interacting with patients.
  • Clean and disinfect the exam and treatment rooms before and after each patient.
  • Use products that are effective against a range of organisms and viruses, including the coronavirus that causes COVID-19.
  • Place signs indicating that rooms have been cleaned; this will assure and comfort patients. Take credit for your infection control processes.

Keep abreast of isolation and precaution guidelines. Based on data available at the time of this article’s publication, the CDC recommends ending isolation and transmission-based precautions for most people with COVID-19 using a symptom-based strategy.14 This limits unnecessary prolonged isolation and use of laboratory testing resources.

Generally, repeat SARS-CoV-2 polymerase chain reaction (PCR) testing is not recommended for “COVID-19 recovered” patients. Specifically, those patients with a prior positive SARS-CoV-2 PCR test result and who have met criteria for isolation discontinuation do not need a follow-up PCR test. A test-based strategy to discontinue isolation and transmission-based precautions is required only for severely immunocompromised patients.15

Prepare for a future COVID-19 surge and review your emergency plan and responses and revise as needed. Review handling of the current pandemic and best practices plus areas of improvement.

Symptom-based criteria for discontinuing transmission-based precautions include the following:

Patients with mild to moderate illness, not severely immunocompromised:

  • at least 10 days have passed since symptoms first appeared and
  • at least 24 hours have passed since last fever without fever-reducing medications and
  • symptoms (cough, shortness of breath) have improved.

Note: For patients who are not severely immunocompromised and are asymptomatic throughout their infection, transmission-based precautions may be discontinued when at least 10 days have passed since the date of their first positive viral diagnostic test.

Patients with severe to critical illness, severely immunocompromised:

  • at least 20 days have passed since symptoms first appeared and
  • at least 24 hours have passed since last fever without fever-reducing medications and
  • symptoms (cough, shortness of breath) have improved.

Note: For patients who are severely immunocompromised and are asymptomatic throughout their infection, transmission-based precautions may be discontinued when at least 20 days have passed since the date of their first positive viral diagnostic test.

Continue to: Strategy 4: Implement frequent employee communication and care...

Pages

Recommended Reading

eConsult Data Shed Light on Care Coordination Decisions During the COVID-19 Pandemic
Covid ICYMI
Telemedicine in primary care
Covid ICYMI
Only 40% of residents said training prepped them for COVID-19
Covid ICYMI
Restructuring health care delivery for the future: What we need to do post–COVID-19
Covid ICYMI
COVID-19: A Dermatologist’s Experience From the US Epicenter
Covid ICYMI
COVID-19 child case count now over 400,000
Covid ICYMI
Patient visits post COVID-19
Covid ICYMI
Hysteroscopy and COVID-19: Have recommended techniques changed due to the pandemic?
Covid ICYMI
COVID-19: New guidance to stem mental health crisis in frontline HCPs
Covid ICYMI
Lifting the restrictions on mifepristone during COVID-19: A step in the right direction
Covid ICYMI